SCHEMBL2737430

SCHEMBL2737430

C/C=C(/O)C(=O)C=C(C)C

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.35
LCK P06239 1/20 0.35
FYN P06241 1/20 0.35
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27458947 0.79 LMNA (0.39) FFAR3LCKFYNKDM4EATM
SCHEMBL8604616 0.78
SCHEMBL8158142 0.75
SCHEMBL12849304 0.73
SCHEMBL5309281 0.69 KDM4E (0.46) FFAR3LCKFYNKDM4EATM
SCHEMBL58395 0.69
SCHEMBL11708907 0.69
SCHEMBL11708915 0.69
SCHEMBL29159287 0.69 ALDH1A1 (0.30) FFAR3LCKFYN
SCHEMBL17771938 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404890-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-11 EP disclosed
EP-2402300-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-04 EP disclosed